The Agentic Inflection Point: Why 2026 Will Separate AI Leaders From Laggards

As we enter the era of agentic AI, here's how organizations can treat this innovation as an operating paradigm.
Opinion

What we lose with remote work—and how to minimize the damage

Offices have historically been where relationships are built and learning happens. The key is figuring out how to keep those things with hybrid work.

Onto Innovation Completes Acquisition of Unique Materials Composition and Electrical Analysis Product Lines from Semilab International

Onto Innovation acquires Semilab USA product lines, boosting advanced materials characterization for logic, memory, and packaging.
Top Speed

Nissan Reveals New Rogue PHEV, With Another Advantage Over The Competition

To compete with Honda and Toyota, Nissan desperately needed a hybrid. Here's how it stacks up to the RAV4 and Honda CR-V.
TMCnet

Accenture Invests in Alembic to Reinvent Marketing Measurement with Data and Causal AI

Accenture (NYSE: ACN) has invested, through Accenture Ventures, in Alembic, a leading AI-powered causal marketing intelligence platform that can determine which marketing campaigns deliver a return on ...

Autonomix Medical, Inc. Reports Positive Subgroup Results Demonstrating Sustained Improvements in Quality of Life from Post Hoc Analysis of Pancreatic Cancer PoC Study

EORTC QLQ-C30 subgroup results confirm broad and durable quality-of-life improvements across disease stages and metastasis status, complementing ...
Le Lézard

Scribe Therapeutics Highlights Data Underpinning its Comprehensive Strategy Targeting Key Lipid Drivers of ASCVD at American Heart Association (AHA) Scientific Sessions 2025

Scribe Therapeutics Inc. ("Scribe"), a genetic medicines company pioneering next-generation in vivo CRISPR-based medicines designed to be safe, durable, and effective enough to become standard-of-care ...